With its low rate of COVID-19 vaccinations, Australia is in the rare position of being able to continue vaccine trials on unvaccinated people. This is especially necessary because even vaccines with high efficacy, such as Pfizer and AstraZeneca, have no guarantee of remaining effective as the virus mutates. Today Cosmos journalist Ellen Phiddian talks to Adelaide’s Dr Chris Rook, fellow of the Royal College of General Practitioners, who will be conducting a phase III clinical trial of a protein vaccine. But even though vaccine trials are necessary, it’s still a long process from conception to approval. So how do you run a vaccine trial in Australia?
Find the science of everything at the Cosmos Magazine website
Subscribe to Cosmos Magazine (print) or the Cosmos Weekly
Watch and listen to all our Cosmos Briefings